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Abstract
Many enveloped viruses invade cells via endocytosis and use different environmental factors as triggers for virus-endosome
fusion that delivers viral genome into cytosol. Intriguingly, dengue virus (DEN), the most prevalent mosquito-borne virus
that infects up to 100 million people each year, fuses only in late endosomes, while activation of DEN protein fusogen
glycoprotein E is triggered already at pH characteristic for early endosomes. Are there any cofactors that time DEN fusion to
virion entry into late endosomes? Here we show that DEN utilizes bis(monoacylglycero)phosphate, a lipid specific to late
endosomes, as a co-factor for its endosomal acidification-dependent fusion machinery. Effective virus fusion to plasma- and
intracellular- membranes, as well as to protein-free liposomes, requires the target membrane to contain anionic lipids such
as bis(monoacylglycero)phosphate and phosphatidylserine. Anionic lipids act downstream of low-pH-dependent fusion
stages and promote the advance from the earliest hemifusion intermediates to the fusion pore opening. To reach anionic
lipid-enriched late endosomes, DEN travels through acidified early endosomes, but we found that low pH-dependent loss of
fusogenic properties of DEN is relatively slow in the presence of anionic lipid-free target membranes. We propose that
anionic lipid-dependence of DEN fusion machinery protects it against premature irreversible restructuring and inactivation
and ensures viral fusion in late endosomes, where the virus encounters anionic lipids for the first time during entry.
Currently there are neither vaccines nor effective therapies for DEN, and the essential role of the newly identified DEN-
bis(monoacylglycero)phosphate interactions in viral genome escape from the endosome suggests a novel target for drug
design.
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Introduction
With almost half of the world’s population at risk for dengue
infections, including life-threatening dengue hemorrhagic fever
and dengue shock syndrome [1], the lack of vaccines and effective
therapies lends urgency to the search for new targets for antiviral
drugs. In this work we have focused on the membrane fusion stage
of DEN infection. As many flaviviruses and alphaviruses, DEN
enters mosquito and human cells by receptor-mediated endocy-
tosis [2–5]. Fusion between the DEN envelope and the endosomal
membrane is mediated by an envelope glycoprotein E [6–9]
structurally similar to E protein of other flaviviruses and to E1
protein of alphaviruses such as Sindbis virus (SIN) [8,10].
Acidification of endosomal content triggers a fusogenic restruc-
turing of protein fusogens and fusion in flaviviruses and
alvaviruses. DEN E undergoes a major conformational change
that starts with the dissociation of the homodimeric form of E.
Separated monomers rise from their initial positions parallel to the
viral envelope to positions perpendicular to the envelope [6–9]. E
monomers interact with the target membrane via their hydropho-
bic fusion loops and assemble into homotrimers that bridge the
viral and target membranes. Subsequent refolding of the E trimer
into its final hairpin structure, with the transmembrane domains
and fusion loops at the same end of the rodlike molecules, bends
the target and viral membranes towards each other and primes
them for fusion [6,8,11–12].
Several observations have suggested that DEN fusion, in
addition to low pH dependence, may involve as-yet-unidentified
cofactors. Early research, confirmed in our preliminary experi-
ments, found that low pH application to adjacent cells with DEN
virions bound to the cell surface resulted in cell fusion for mosquito
cells [13–15] but not for mammalian cells [13]. Furthermore,
during viral entry into mammalian cells most DEN particles fuse
only when they get to late endosomes/lysosomes [3–5], and, thus,
they neither fuse nor become inactivated in early endosomes,
which are expected to have pH low enough to trigger
conformational changes in DEN E and induce DEN-mediated
fusion between mosquito cells [15]. We suggested that in analogy
to alphavirus fusion dependence on lipid cofactors (namely,
cholesterol and sphyngomyelin) [16–19], the apparent differences
in fusogenic properties of DEN towards different target mem-
branes may reflect differences in their lipid composition. In
contrast to the outer leaflets of plasma membranes of mammalian
cells and to the inner leaflets of membranes of early endosomes,
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the membranes of late endosomes of mammalian cells have high
concentrations of the anionic lipids (AL) phosphatidylserine (PS)
[20] and bis(monoacylglycero)phosphate (BMP) [21], respectively.
In this work, we explored the dependence of fusion of DEN,
serotype 2, strain TH-36 (below referred to as ‘‘DEN’’) on the lipid
composition of the target membranes and found this fusion
reaction to require the presence of AL. Liposomal, plasma, and
intracellular membranes that did not support DEN fusion became
fusion-competent upon addition of AL such as BMP and PS. The
discovered dependence on AL was also observed for dengue virus
serotype 2, strain New Guinea C and for dengue virus, serotype 4,
strain H241. AL acted downstream of low pH-dependent stages of
DEN fusion and promoted an advance of the fusion process
beyond the earliest hemifusion intermediates. Endocytosed viral
particles are acidified, and thus the restructuring of DEN E
towards its fusogenic conformations is expected to be triggered
before DEN comes into contact with the AL-containing
membranes of late endosomes. For many viruses, including
influenza virus [22] and SIN [17], premature activation of the
viral fusion machinery by an acidic medium in the absence of a
target membrane results in a quick inactivation of the machinery.
In contrast, we found that DEN particles treated with a low-pH
medium in the presence of AL-free target membranes retain their
fusogenic properties for a relatively long time (.30 min). This
unusually slow inactivation may explain the preservation of
fusogenic properties of DEN for the duration of viral trafficking
from early to late endosomes. We propose that the AL dependence
and the delayed inactivation of the fusion machinery of DEN play
an important role in defining the timing and location of the fusion
stage of viral entry.
Results
DEN does not fuse plasma membranes of mammalian
cells
The fusogenic activity of diverse enveloped viruses is often
characterized by measuring fusion between adjacent cells that is
mediated by viral particles associated with the cell surface either
through non-specific binding or through virus–receptor docking.
For viruses that fuse in acidified endosomes, activation of viral
fusogens and cell-to-cell fusion yielding syncytia is triggered by a
short-term application of acidic pH. In agreement with earlier
reports [13], DEN effectively fused mosquito cells C6/36
(Fig. 1A,B). Fig. 1B, curve 1 represents the pH dependence of
DEN-mediated fusion of these cells and, as expected [15], already
shows significant fusion at moderately acidic pH.
In striking distinction from insect cells, DEN produced in either
insect or mammalian cells did not induce syncytium formation for
any mammalian cells we tested (Vero, BHK21, CHO-K1,
MA104, NIH 3T3, HAb2, BS-C-1, U967 (monocytes), and Raw
(macrophages)) in the experiments in which cells pre-incubated
with DEN were treated for 1 to 15 min with an acidic medium of
pH values ranging from 4.9 to 6.5. Syncytium formation involves
both the fusogen-dependent opening of fusion pores and their cell-
machinery-dependent expansion, yielding a cell-size lumen [23].
We found that the absence of DEN-induced syncytia for
mammalian cells reflects the inability of DEN to form fusion
pores large enough to pass GFP and mRedFP, as evidenced by the
lack of double-labeled cells (shown for Vero cells in Fig. 1C).
In parallel experiments, we contrasted the fusogenic activity of
DEN with the well-characterized fusogenic activity of SIN, a virus
that utilizes similar fusion machinery [8]. As expected, SIN
effectively fused both mammalian cells and mosquito cells C6/36
(Fig. 1A; B, curve 2; and 1C; see also [24]).
We explored whether the inability of DEN to fuse mammalian
cells can be explained by inefficient virus–cell-surface binding. To
evaluate the binding (including non-specific receptor-independent
binding), we incubated Vero cells (Fig. 1D) or CHO-K1 cells (not
shown) with mildly biotinylated DEN or SIN particles, applied
fluorescence-tagged streptavidin, and then carried out flow
cytometry analysis (Fig. 1D). We found virus–cell binding for
DEN to be somewhat higher than for SIN, the virus that
effectively fuses the cells indicating that cell fusion for DEN is
blocked downstream of cell-surface binding.
This conclusion was further substantiated by comparing DEN
binding to C6/36 cells that were readily fusable by the virus with
DEN binding to mammalian cells (MA104 cells) that did not fuse
in the presence of DEN. In these experiments, we blocked
internalization of DEN virions labeled with a fluorescent lipid DiD
by low temperature (10uC) and quantified viral binding by
measuring DiD fluorescence associated with the cells (Fig. S1).
To take into account the very different sizes of C6/36 and MA104
cells, we normalized the amount of DiD fluorescence associated
with the plasma membrane of the cells to the fluorescence of
membrane probe NBD-tagged phosphatidylcholine (NBD-PC).
This normalization is based on the assumption that NBD-PC
similarly partitions into the outer leaflets of plasma membrane
bilayers of C6/36 and MA104 cells and, thus, the cell-associated
NBD fluorescence is proportional to the total area of plasma
membranes. As shown in Fig. S1, under the conditions of our cell-
to-cell fusion experiments on C6/36 cells and on MA104 cells, the
ratios of DiD- and NBD- fluorescences, and thus the surface
densities of DEN virions at plasma membrane, were very close.
This finding argues against the hypothesis that DEN fuses C6/36
cells but does not fuse mammalian cells because of a large
difference in the amounts of cell-bound virions.
To summarize, while DEN binds to and effectively infects both
mosquitoandmammaliancells,inourexperimentsitfusedmosquito
but not mammalian cells. The inability of DEN to fuse the plasma
membranes of the virus-permissive mammalian cells indicated that
the fusogenic activity of DEN depends on the target membrane. To
identify the cofactors that have to be present to support DEN fusion,
Author Summary
Dengue virus infection is a growing public health problem
with up to 100 million cases annually, and neither vaccines
nor effective therapies are available. To search for the ways
of preventing and treating dengue infections we need to
better understand their molecular mechanisms. As with
many other viruses, dengue virus enters cells by fusion
between the viral membrane and the membrane of
intracellular vesicles (endosomes). In this work we explored
the fusion stage of dengue virus entry in different
experimental systems ranging from virus fusion to artificial
lipid membranes to fusion inside the cells. While earlier
work on dengue virus entry has focused on viral protein
that mediates fusion, we found that effective action of this
protein requires specific lipid composition of the mem-
brane the virus fuses to. In effect, this lipid dependence
allows virus to control intracellular location of the fusion
event and, thus, the place of its RNA release by exploiting
cell-controlled differences between lipid compositions of
different organelles the virus travels through. The essential
role of the interactions between dengue virus and its lipid
cofactors during viral entry suggests that these interac-
tions may be targeted in drug design.
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endosomal membranes that DEN fuses with to inject its RNA into
cells. Using liposomes, we explored the dependence of DEN fusion
on the composition of the target membrane.
Virus-liposome fusion
To study the role of membrane lipid composition in DEN
fusion, we measured low pH-induced lipid mixing between DEN
particles labeled with a self-quenching concentration of a
fluorescent lipid, DiD, and unlabeled liposomes of different
composition. Only slow and inefficient lipid mixing between
DEN and liposomes was observed for liposomes formed from
lipids characteristic of the outer leaflet of the plasma membranes of
mammalian cells (PM composition) (Fig. 2A,B). In contrast, we
observed robust lipid mixing between DEN and liposomes
containing phospholipids characteristic of late endosomal mem-
branes (LEM composition). A much higher efficiency of DEN
fusion to LEM liposomes than to PM liposomes was also observed
for dengue virus serotype 4, strain H241 (Fig. S2) and for dengue
virus, serotype 2, strain New Guinea C (not shown).
As expected [19], including Chol into the LEM lipid mixture
(LEM-Chol composition) did not significantly change the initial
rate or the extent of lipid mixing detected at t=10 min (Fig. 2A,B).
Inactivation of DEN particles by pre-incubation at pH 4.5 for
Figure 1. In contrast to SIN, DEN fuses mosquito cells but does not fuse mammalian cells. A. Fusion of mosquito cells C6/36 mediated by
DEN (middle image) and SIN (image at the bottom) was triggered by a 15-min application of a pH 5.3 medium, 37uC. Images were taken after 2-h
incubation in complete medium at 37uC. Arrows mark characteristic syncytia. Image at the top presents the control experiment in which pre-
incubation with virions was omitted. B. pH dependencies of fusion between C6/36 cells mediated by DEN and SIN (triangles and circles, respectively).
Fusion between cells with bound DEN- or SIN- virions was triggered at 37uC by a 15-min application of medium of a given pH. Efficiency of syncytium
formation was determined by measuring a decrease in the number of mononucleated cells 2 hours later. C. Co-plated EGFP-expressing (green) and
mRedFP-expressing (red) Vero cells were pre-incubated with DEN (middle image) or SIN (image at the bottom) and fusion was triggered by a 5-min
application of a pH 5.3 medium. Double-labeled multinucleated cells (marked by arrows) were observed in the experiments with SIN but not in the
experiments with DEN (image at the bottom). Image at the top presents the control experiment in which pre-incubation with virions was omitted.
Images were taken 30 min after the end of the low pH application. D. The difference in the ability of DEN and SIN to fuse mammalian cells cannot be
explained by the difference in virus-cell binding. Binding of DEN and SIN to Vero cells was evaluated using surface-biotinylated virions. Cells with
associated virions were treated with streptavidin Alexa Fluor 488 conjugate and cell-associated fluorescence was analyzed by flow cytometry analysis.
The bars present mean fluorescence values measured for cells incubated with biotinylated DEN (taken as 100%) or SIN and then streptavidin. ‘‘No
virus’’ - cells were not incubated with virions but were incubated with streptavidin. ‘‘No SA’’ - cells were incubated with biotinylated DEN but
streptavidin application was omitted. ‘‘No Biotin’’ - cells incubated with DEN virions, which were not biotinylated, were then incubated with
streptavidin. B&D .The data are presented as means +/2 s.d. (n$3).
doi:10.1371/journal.ppat.1001131.g001
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ocarbonate (DEPC) [25], resulted in a loss of DEN fusogenic
properties (Fig. 2A). We also found that lipid mixing between DEN
and LEM liposomes was inhibited by DEN monoclonal antibody
4G2 [26] (data not shown).
The inefficient fusion between DEN and liposomes containing
lipids characteristic of plasma membranes contrasted with the
robust fusogenic activity of SIN (Fig. S3). At pH 5.3, the initial rate
and extent of lipid mixing with PM liposomes at t=10 min for SIN
were 10 fold and 3 fold higher than those for DEN. Strong lipid
mixing between SIN and these liposomes is in agreement with
earlier reports [17] and is also consistent with efficient fusion
between alphaviruses and plasma membranes of mammalian cells
(see above and [27–29]). Lipid mixing between SIN virions and PM
liposomes developed slower than that between SIN and LEM-
cholesterol liposomes but reached similar extents. Note that the rate
of SIN-liposome lipid mixing detected in our experiments using the
DiD dequenching assay is notably lower than that reported in
[17,30] and closer to the rates reported in [31–32]. This divergence
most likely reflects the differences in assays used by different groups.
We hypothesized that LEM liposomes support DEN fusion
because these liposomes containan AL BMP, a specific lipid marker
of multivesicular late endosomes that is present in different
membrane domains of these organelles in concentrations between
20 and 70 mol% [21]. To test this hypothesis, we used liposomes of
simpler compositions. While DEN did not fuse with liposomes that
were formed from phosphatidylcholine (PC), liposomes that in
addition to PC contained 30 mol % of either BMP or phosphati-
dylglycerol (PG) or PS supported lipid mixing (Fig. 2C), indicating
that DEN fusion to liposomes depends on the negative charge of the
target membrane rather than on a specific polar group of AL.
Anionic lipids support DEN fusion to cell membranes
We then tested whether the inability of DEN to fuse mammalian
cells can be explained by the lack of AL in the outer leaflet of the
plasma membrane. We incubated CHO-K1 cells with the virus;
then, after a wash, we placed the cells at 4uC and treated them with
exogenous AL, PS. After a wash, we applied a low-pH medium at
room temperature to trigger fusion. DEN effectively fused PS-
treated cells but did not fuse untreated cells (Fig. 3A,B). While PS
added to the outer leaflet of plasma membranes of mammalian cells
undergoes inward transmembrane redistribution mediated by ATP-
dependent aminophospholipid translocases [33], at the time of low
pH application significant percentage of exogenous PS remained in
the outer leaflet, as evidenced by its accessibility for extraction with
bovine serum albumin, BSA (data not shown). Furthermore, DEN
fusion of mammalian cells was similarly supported by addition of
PG, an AL that is not an aminophospholipid (Fig. 3B). In control
experiments, DEN did not mediate fusion between CHO-K1 cells if
cell membranes were not supplemented with exogenous lipid or
were supplemented with PC (Fig. 3B). In similar experiments
carried out with SIN, we found cell fusion mediated by this virus to
be almost unaffected by addition of either PS or PG (Fig. S4).
Since AL were applied only after removal of unbound DEN, the
dramatic increase in fusion after PS treatment cannot be explained
by a better DEN binding. We directly verified that cells treated
and untreated with PS carried similar amounts of DEN particles in
experiments with fluorescence-labeled viral particles. CHO-K1
cells were incubated with DiD-labeled virus at 10uC and washed.
The temperature was lowered to 4uC and cells with associated
virus were either treated or not treated with PS and then
solubilized with 1% Triton X-100 at room temperature to
dequench the DiD. The levels of fluorescence measured for
samples from PS-treated and untreated cells were statistically
indistinguishable.
As for many other enveloped viruses, fusion of DEN to the
plasma membrane can be indirectly evaluated by measuring cell
infection caused by low pH-induced fusion at the cell surface
under conditions where acidification of the endosomes, essential
for the biologically relevant entry pathway, is blocked [34]. We
Figure 2. The dependence of DEN fusion to liposomes on anionic lipids. A. Lipid mixing between DiD-labeled DEN virions and liposomes of
LEM-Chol (1); LEM (2); and PM (3) compositions (pH 5.3, 37u) assayed as DiD dequenching. 4 & 5 –LEM liposomes with DEN virions inactivated by pre-
incubation at pH 4.5 or by DEPC. 6 –DEN and LEM liposomes at pH 7.8. B. The extent of the lipid mixing between DEN and LEM- (1); LEM-Chol- (2)
and PM- (3) liposomes at different pH observed 10 min after acidification. Insert –initial rates of lipid mixing between DEN and LEM- (1); LEM-Chol- (2)
and PM - (3) liposomes at different pH. C. Fusion between DEN virions and liposomes formed of mixtures of 70 mol % PC and 30 mol % of either BMP
or PG or PS or liposomes formed of PC was measured at pH 5.3 and quantified as initial rates of lipid mixing (black bars, BMP-containing liposomes
(‘‘BMP’’) taken as 100%) and the extents of the lipid mixing at t=10 min (grey bars). The data in B and C are presented as means +/2 s.d, n$3.
doi:10.1371/journal.ppat.1001131.g002
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and mammalian cells (MA104, Vero and BHK21) to require a
very high concentration of virions: 300 infectious units/cell (at
least 10 times higher than the number of infectious viral particles
per cell we had to use in FIA for mosquito C6/36 cells, data not
shown). In this setting, FIA, while indirect, may be a very sensitive
assay for fusion since fusion of a single virion out of hundreds may
result in infection. As for DEN-mediated cell-to-cell fusion, the
anionic lipids (PS or PG)-supplemented MA104 cells demonstrat-
ed much higher (15-fold) levels of fusion in FIA (Fig. 3C). Note that
DEN-dependent fusion of PS-treated cells was still dependent on
low pH. We observed a similar promotion of fusion-infection for
Vero and BHK21 cells (data not shown).
The importance of AL for DEN-plasma membrane fusion was
further confirmed in the experiments on mosquito cells. As
mentioned above, C6/36 cells were reported to expose unusually
high concentrations of AL at their surface [20]. In agreement with
this study, we found a much higher cell-surface labeling with R-
phycoerythrin -tagged annexin V for C6/36 than for MA104 cells
(Fig. S5). Blocking PS and perhaps other AL [35] exposed at the
surface of C6/36 cells with annexin V inhibited DEN-mediated
fusion between these cells (Fig. 3D). While SIN-mediated fusion
Figure 3. Anionic lipids promote DEN-mediated cell-to-cell fusion. A. Fluorescence microscopy images of co-plated EGFP-expressing (green)
and mRedFP-expressing (red) CHO-K1 cells with pre-bound DEN treated with a pH 5.3 medium for 5 min (image on the left). Image on the right –
Fusion of the cells treated with PS prior to a low pH application results in the appearance of fused co-labeled cells (marked by arrows). Cartoon at the
top of A summarizes the experimental protocol used to supplement plasma membranes of CHO-K1 and other cells with anionic lipids. B. DEN-
mediated fusion between CHO-K1 cells treated with PC, PS, or PG or with no exogenous lipids (control) immediately prior to a 5-min pH 5.3
application. (PS, no DEN) – the cells treated with PS and low pH in the absence of DEN. (PS, no low pH) – the cells with bound DEN treated with PS but
not with low pH. C. Low pH-dependent fusion between DEN and plasma membrane of MA104 cells supplemented or not supplemented with PS or
PG was evaluated as infection under conditions when endocytic entry of the virus was blocked. In the negative controls, the cells not treated (No low
pH) or treated with PS (PS, no low pH) were not incubated at acidic pH. (Low pH), (PS, low pH) and (PG, low pH), – the cells not treated with
exogenous lipids (taken as 100%), or treated with either PS or PG, respectively, were incubated at pH 5.3 for 5 min at room temperature. D. Fusion
between mosquito cells C6/36 mediated by either DEN or SIN at pH 5.3 and by DEN at pH 6.2 is inhibited by blocking AL at the cell surface with
annexin V (blue bars). (green bars) – no annexin. Note that annexin V inhibition of DEN-mediated fusion of C6/36 cells at pH 5.3 is much stronger than
that for SIN-mediated fusion. B, C, D. The data are presented as mean +/2 s.d, n$3.
doi:10.1371/journal.ppat.1001131.g003
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because of a steric hindrance, inhibition of the DEN-fusion was
much stronger. These findings support the hypothesis that the
known ability of DEN to fuse C6/36 cells reflects the elevated
concentrations of externalized AL in their membranes.
In brief, as with DEN-liposome fusion, the efficiency of DEN
fusion to plasma membranes correlates with the accessibility of AL.
Both DEN fusion within the endocytic pathway and viral
infection depend on anionic lipids
The effects of AL on fusion events during viral infection were
studied in MA104 cells and BS-C-1 cells with pre-bound DEN
labeled with DiD in a self-quenching concentration. Viral fusion
events along the endocytic pathway diluted DiD and, thus,
significantly increased cell fluorescence (Fig. 4A and S6). While
first fusion events were observed less than 5 min after the rise in
temperature to 37uC, most viral particles fused only at later times,
with a median waiting time of ,15 min (Fig. S6), consistent with
an earlier study [3]. As expected, no intracellular fusion was
observed when endosomal acidification was blocked by chloro-
quine or when DEN was DEPC-inactivated (Fig. 4A,B). In
agreement with reports suggesting that DEN fusion reactions take
place in late endosomes [3–5], we found that microtubule-
depolymerizing nocodazole known to disrupt endosomal traffick-
ing from early to late endosomes/lysosomes [36] inhibits
intracellular fusion of DEN. When cells with pre-bound DEN
were treated with AL (5-min, 4uC) before warming up to 37uC, we
observed a dramatic increase in the average cell fluorescence
(Fig. 4A,B). As for untreated cells, the increase in fluorescence of
PS-treated cells was inhibited by chloroquine. The increase in DiD
fluorescence reflects a higher efficiency of DEN–endosome fusion
and suggests that in the AL-treated cells DEN fuses in early
endosomes that normally would not have AL. This conclusion was
further substantiated by the finding that intracellular fusion of
DEN in AL-treated cells was much less sensitive to inhibition of
endosomal trafficking by nocodazole than in untreated cells
(Fig. 4B). Promotion of intracellular fusion for PS-supplemented
cells was also observed for dengue virus of serotype 2, strain New
Guinea C (not shown).
One may expect the delivery of DEN virions to late endosomal
compartments that support viral fusion to be blocked by a
dominant negative Rab7 (DN Rab7) that disrupts late endosomal/
lysosomal biogenesis. Indeed, at least for some strains of DEN, DN
Rab7 inhibits the infection of mammalian cells and DEN fusion
[3]. As expected, we found that EGFP-tagged DN Rab7a S22N
expression inhibits intracellular fusion of DiD-labeled DEN in
MA104 cells, as evidenced by a much lower DiD fluorescence
associated with DN Rab7-expressing cells detected by the EGFP
fluorescence (Fig. S7A). Treating the cells with PS alleviated the
DN Rab7 inhibition, as evidenced by the appearance of cells
displaying both DiD- and EGFP- fluorescence (Fig. S7B). These
findings further substantiate our hypothesis that DEN delays its
fusion until entry into late endosomes because of the AL-enriched
lipid composition of their membranes and does not fuse in early
endosomes because these organelles normally do not have anionic
lipids.
Since fusion is an early stage of DEN infection, promotion of
DEN fusion in endosomal compartments may promote DEN
infection. We extended our work from fusion assays to infection
analysis and explored the effects of AL on the physiologically-
relevant pathway of infection via endocytosis. A strong (,16-fold)
promotion of infection for cells supplemented with PS or PG
(Fig. 4C) indicates that the AL dependence of DEN fusion results
in a corresponding dependence of viral infection.
Inactivation of DEN fusion machinery
Conformational changes of DEN E and DEN fusion with insect
cells are already triggered at the moderately acidic pH (,pH 6.0)
Figure 4. Anionic lipids promote DEN-mediated intracellular fusion and viral infection. A. An increase in the cell fluorescence upon fusion
of DiD-labeled DEN within the endocytic pathway of MA104 cells. Images were taken 40 min after raising the temperature to allow internalization of
the virus for PS-treated cells (PS-cells), untreated cells (Control) and untreated cells with DEPC-inactivated DEN (DEPC DEN). B. Intracellular DEN fusion
was quantified as the mean total fluorescence per imaging field for: untreated MA104 cells (control, taken as 100%); cells pre-treated with either
nocodazole (Nocod) or chloroquine (Chloroq); cells with DEPC-inactivated virus (DEPC); cells treated with PG (PG), cells pretreated with nocodazole
and then treated with PG (PG&Nocod); cells treated with PS (PS), cells pretreated with chloroquine or nocodazole and then PS (PS & Chloroq and
PS&Nocod). C. Promotion of DEN infection for MA104 cells treated with PS (PS) or PG (PG). Control – no exogenous lipids, taken as 100%. DEN
infection of the cells treated or not treated with PS is inhibited by chloroquine (Chloroq & PS and Chloroq, respectively). B, C. The data are presented
as mean +/2 s.d, n$3.
doi:10.1371/journal.ppat.1001131.g004
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early endosomes. While premature activation of most viral
fusogens inactivates them [37], inactivation of DEN has to be
relatively slow to keep viral fusion machinery functional until the
virus reaches late endosomes. Indeed, we found that more than
half of DEN particles remained fusogenic towards LEM-liposomes
after a 15-min pre-incubation at pH 5.5 either in the absence of
the target membranes or in the presence of fusion-incompetent PC
liposomes (Fig. 5A). Low pH exposure of DEN at the surface of
MA104 cells resulted in similarly slow inhibition of subsequent
intracellular fusion (Fig. 5B). Since most of the endocytotic cargo
reaches late endosomes within 15 min [38], we concluded that the
inactivation of DEN at acidic pH is slow enough to preserve the
virus’s fusogenic properties during its trafficking from early to late
endosomes.
The lack of anionic lipids blocks DEN fusion downstream
of low-pH-dependent stages and restricted hemifusion
intermediates
Which of the stages of the fusion pathway mediated by DEN E
protein depends on the AL presence in the target membranes?
Diverse fusion processes start with a local merger of contacting
leaflets of two membranes, a stage referred to as hemifusion [39].
However, lipid flow through the earliest hemifusion intermediates
may be restricted by the proteins surrounding the fusion site [39].
These ‘restricted hemifusion’ intermediates (RH) can be trans-
formed into complete fusion with chlorpromazine (CPZ). Inverted-
cone shaped CPZ preferentially partitions into the inner leaflets of
cell membranes and breaks hemifusion structures composed solely
of these leaflets [40]. To test whether DEN E forms RH
intermediates, we used the experimental system of HAb2 cells
with pre-bound human red blood cells (RBC) [41–42] utilized in
earlier studies on RH [43]. HAb2 cells express HA0, an uncleaved
form of influenza hemagglutinin that mediates very tight binding
between HAb2 and RBC but is fusion-incompetent [43]. We
allowed DEN to bind to HAb2 cells for 30 min at 10uC, then
added RBCs labeled with a fluorescent lipid PKH26 and 15 min
later washed out unbound virus and RBCs. Low pH application to
HAb2–DEN–RBC complexes yielded no lipid mixing, unless the
cells were pre-treated with PS (Fig. 6A). However, robust fusion
was observed for cells not treated with PS when low pH pulse was
followed by an immediate application of CPZ indicating that
DEN-mediated HAb2-RBC fusion was blocked at the stage of RH
intermediates.
The extents of lipid mixing gradually decreased when we
extended the time interval between the end of low pH application
and the CPZ pulse, indicating that RH formed by DEN E
dissociated with time (Fig. 6B). This is similar to RH in fusion
mediated by influenza and SIN viruses [43]. Likewise, 40% of cell
complexes developed lipid mixing when PS was applied 5 min
after the end of a 1-min pulse of pH 5.3, with much lower lipid
mixing observed when PS was applied 30-min after the end of the
low pH pulse. These findings indicated that pre-lipid-mixing
fusion intermediates formed by low-pH-conformations of DEN E
advanced to yield lipid mixing in the presence of AL indepen-
dently of low-pH but dissociated with time in the absence of AL.
To summarize, DEN-AL interactions facilitate the transition
from RH to more advanced fusion intermediates. The AL
dependence of this transition distinguishes fusion machinery of
DEN from that of SIN. As expected [43], SIN effectively mediated
lipid mixing between RBC and HAb2 cells not treated with PS
and CPZ application strongly promoted SIN-mediated fusion only
for suboptimal pH showing that for pH#5.8 most of the RH
intermediates advanced to yield lipid mixing without CPZ
application (Fig. S8).
Discussion
This study developed from our analysis of the intriguing finding
that while DEN effectively infects mammalian cells, it has a very
low level of fusogenic activity towards the plasma membranes of
Figure 5. Slow inactivation of fusion machinery of DEN virions acidified in the absence of AL-containing membranes. A. DiD-labeled
DEN virions were pre-incubated at pH 5.5 for 15 or 30 min in the absence of liposomes or in the presence of PC liposomes (+PC LP); or at pH 4.5 for
30 min in the absence of liposomes. After low pH pre-treatment, virions without re-neutralization were mixed with LEM liposomes at pH 5.5. The
initial rates of lipid mixing (black bars) and the extents of lipid mixing at t=10 min (gray bars) were normalized to those between DEN and LEM
liposomes observed without low pH-preincubation (Control). B. MA104 cells with pre-bound DiD-labeled DEN were pre-treated or not pre-treated at
37uC with pH 6.0 or 5.5 medium (15 min, 37uC). Low pH application was followed by a 40-min incubation in the complete medium at 37uC. Viral
fusion events along the endocytic pathway were detected as an increase in the mean total fluorescence per imaging field. Control – no low pH pre-
treatment, taken as 100%. A, B. The data are presented as mean +/- s.d. (n=3).
doi:10.1371/journal.ppat.1001131.g005
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membranes that DEN fuses with during infection [3–5] contain
cofactors for DEN fusion machinery missing in the plasma
membrane. In our search for these cofactors, we have focused on
the unusual lipid composition of the late endosomal membrane
and found that the AL highly enriched in these membranes are
indeed required for low-pH-dependent DEN fusion. Since in
mammalian cells DEN comes into contact with AL-enriched
membrane leaflets only in late endosomes, the AL dependence of
DEN fusion likely determines the timing and the place of the
release of the viral RNA into the cytosol.
The mechanism of AL dependence
All membrane fusion reactions are expected, and in many cases
shown, to depend on the lipid composition of the membranes. Some
dependencies are conserved among fusion processes driven by very
diverse fusogens [39]. In contrast, the essential role of AL for DEN
fusion is not conserved even within the same class (II) of viral protein
fusogens. In spite of similarities between the structures of the
fusogens utilized, another flavivirus, TBE, and alphaviruses such as
SIN effectively fuse with AL-free target membranes [44–45].
Interestingly, although it is AL-independent, the fusion of alpha-
viruses including SIN does require the specific lipids cholesterol and
sphingomyelin as cofactors for the protein machinery [46–48], and
neither of these lipids is required for DEN fusion.
The specific mechanisms by which DEN E interactions with AL
control E restructuring and fusion remain to be clarified. To start
with, the local pH near a membrane containing AL is lower than
the pH in the bulk of the solution because of the accumulation of
protons near the negatively charged lipid headgroups. The
changes in ion concentration at a charged surface are described
by the Gouy-Chapman theory that yields the relation between the
surface charge density, the electrostatic potential, the ionic
strength of the solution and ion distributions near charged
membranes [49]. An estimate based on the Gouy Chapman
theory suggests that for a bilayer containing 30 mol% AL in
100 mM NaCl buffer, the apparent pH dependence of fusion may
be shifted to a less acidic pH by up to 0.7 units. However, while
DEN fusion with liposomes containing 30 mol% PS was already
observed at pH 6.8, there was almost no lipid mixing for AL-free
PC liposomes even at pH 4.5 (not shown). Thus, the AL-induced
shift of local pH does not fully explain the role of AL as a
prerequisite for DEN fusion. Note that pH dependences of fusion
observed for dengue virus in different assays somewhat differ (see
for instance, Fig. 1B and Fig. 2B). These differences likely reflect
different numbers of activated fusion proteins required to reach
detectable fusion stages for different target membranes.
In the fusion pathway mediated by several viruses, RH is
followed by more-energy intensive stages that culminate in
opening of an expanding fusion pore [39,43]. While DEN forms
the RH intermediates in the absence of AL, the later stages of
DEN fusion require interactions between E protein and AL. In
alphavirus fusion, the lipid cofactor cholesterol promotes the
insertion of E1 fusion loops into the target membrane and
formation of functional E1 homotrimers [47]. In analogy to this
mechanism, we propose that the completion of DEN fusion
requires E assembly into stable trimers dependent on interactions
between the fusion loop of DEN E and AL in the target membrane
(Fig. 7). Indeed, for a synthetic peptide representing the fusion loop
region of DEN peptide, insertion into the lipid bilayer and
peptide–peptide interactions at the bilayer surface are promoted in
the presence of AL [50].
Figure 6. The lack of anionic lipids blocks fusion advance beyond restricted hemifusion intermediates. A. pH dependence of the DEN-
mediated fusion between HAb2 cells and PKH26-labeled RBC for the cells treated or not treated with PS and/or with CPZ. Fusion was triggered by a
5 min application of a given pH and assayed as a percentage of HAb2-DEN-RBC complexes demonstrating lipid mixing. HAb2-DEN-RBC complexes
were treated with neither PS nor CPZ (untreated cells); with PS immediately prior to low pH application (PS-treated cells); with CPZ pulse immediately
after the end of low pH application (untreated cells + CPZ); with PS immediately prior to low pH application and with CPZ pulse immediately after the
end of low pH application (PS-treated cells + CPZ). B. The loss of ability of AL added after low pH pulse to support DEN-mediated fusion correlates
with dissociation of DEN E-formed restricted hemifusion intermediates. CPZ pulse (striped bars) or PS (gray bars) were applied immediately after the
end of a 5-min incubation of HAb2-DEN-RBC complexes at pH 5.3 medium (t=0, taken as 100%); 5-min or 30- min later. Control –HAb2-DEN-RBC
complexes treated with neither CPZ nor PS. A, B – the data presented as mean +/- s.d., n$3.
doi:10.1371/journal.ppat.1001131.g006
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To facilitate the development of antivirals targeting the fusion
stage of DEN entry it is important to have a reliable quantitative
approach that may be used in a high throughput in vitro screening.
In the most recent studies [11,51], DEN fusion to liposomes has
been detected by exposure of the viral core protein to liposome-
encapsulated trypsin. A successful application of this approach
(first developed for another virus in [52]) to DEN is an important
advance. However this approach is difficult to quantify and still
needs to be validated by excluding the possible role of leakages
[52] that may accompany DEN-target membrane interactions at
acidic pH [51]. For many viruses, including SIN and some
flaviviruses, fusogenic activity can be conveniently monitored
by measuring lipid mixing between viruses and liposomes
[16–17,19,30–32,44,52–55]. However, development of a lipid
mixing assay for DEN fusion has proved to be surprisingly
challenging [56]. Our work explains the very low efficiency of lipid
mixing between DEN virions and AL-free liposomes [11] and
describes a simple fluorescence dequenching assay of fusogenic
activity of DEN towards AL-containing liposomes.
In addition to a lipid mixing assay that characterizes fusion
between DiD-labeled DEN and liposomes by measuring DiD
dequenching, we also used DiD-labeled virions to develop the
intracellular DEN fusion assay. Our assay is based on earlier work
[3,57] that elegantly explored the DEN entry pathway in living
cells by following a single DiD-labeled DEN particle using real-
time fluorescence microscopy. In our approach, instead of detailed
characterization of the time course and localization of the DEN
fusion events for ,50–100 virions achieved in [3,57], we have
focused on developing a much simpler approach characterizing
intracellular DEN fusion as averaged over thousands of virions
and cells. We expect our quantitative assays of DEN fusion within
cells and with liposomes to be of help in screening for potential
anti-DEN drugs.
The biological relevance of AL dependence
Viruses have developed different strategies to prevent the
premature release of the conformational energy of their protein
fusogens that would result in irreversible ‘‘discharge’’ or in
undesirable fusion. For many viruses, including DEN, which utilize
low pH-dependent fusogen proteins, these proteins are synthesized
in an inactive form and then are converted to a mature fusion-
competent form by proteolytic cleavage of the fusogen itself or an
accessory protein [6–7,10]. However, viral fusogens such as DEN E
that can be activated at pH values close to neutral may need
additional mechanisms for avoiding premature release of the
conformational energystored inthe proteins. Ourfindingthat DEN
neither fuses nor rapidly inactivates in the absence of AL-containing
target membranes suggests that AL dependence of DEN prevents
functional inactivation of the virus until it reaches AL-enriched late
endosomes (Fig. 7). RH connections provide an additional receptor-
independent docking mechanism that holds viral and endosomal
membranes in tight contact. Within multivesicular endosomes, the
virus can fuse either to the limiting membrane or to the internal
vesicles that contain the highest concentration of AL BMP [21]. In
the latter case, viral RNA release requires an additional fusion
event: BMP-dependent but likely DEN E-independent back-fusion
between the internal vesicle and the limiting membrane. Back-
fusion has been proposed as a mechanism for endosome-to-cytosol
transport of RNA of vesicular stomatatis virus ([58], but see [59]).
Our work concentrates on fusion mediated by DEN serotype 2,
strain TH-36. While experiments on virus/liposome lipid mixing
for dengue virus of serotype 4, strain H241 (Fig. S2) and
experiments on virus/liposome lipid mixing and intracellular
Figure 7. The schematic diagram that illustrates the proposed mechanism of DEN entry. Left panel (A, B, C) illustrates enlargement of the
fusion intermediates corresponding to distinct stages of viral entry shown in the right panel (A’,B’, C’). A. Initial state of membrane contact. DEN E lays
along the surface of the viral envelope. B. Acidification in the presence of AL-free target membrane (for instance, in the early endosome) destabilizes
the E dimers and allows E monomers to interact with the target membrane. These interactions result in formation of the earliest hemifusion
intermediates that do not support lipid mixing between the membranes. C. Protein E interaction with AL-enriched target membrane (for instance,
late endosomal membrane) allows productive insertion of the fusion loop of E required for homotrimerization of E protein. Homotrimers of E drive
the transition from restricted hemifusion to complete fusion. The panel on the right (A’, B’, C’) summarizes the proposed pathway of the DEN entry.
While endocytosed viral particles in early endosomes are already exposed to environment acidic enough to trigger conformational changes in DEN E
(B’), most of the virions neither inactivate nor advance in fusion beyond restricted hemifusion until microtubule-dependent trafficking delivers them
into the late endosomal environment and, for the first time during entry, virions come into contact with an AL-enriched target membrane (C’). Virion
fusion to the AL BMP-enriched membrane of late endosomes (shown in green) delivers viral RNA to its translation-replication sites at pre- and post-
lysosomal vacuoles.
doi:10.1371/journal.ppat.1001131.g007
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that these viruses have a similar dependence on AL, DEN virions
of different serotypes and strains may use alternative pathways for
their entry into mammalian cells [60–61]. Future research will
clarify the applicability of the AL-dependent mechanism of timing
viral fusion to the entry into late endosomes for different
serotypes/strains of DEN.
To summarize, the AL dependence of DEN fusion identified in
our work suggests a novel mechanism allowing viruses to exploit
cell-controlled changes in membrane lipid composition. In this
mechanism, internalized virus uses the specific lipid composition of
late endosomes highly enriched in AL as a way of timing fusion to
deliver viral RNA to its translation-replication sites effectively. We
hope the assays developed in this study to directly characterize
DEN fusion will help in developing antivirals including those
targeting DEN-AL interactions to block or prematurely activate
DEN E refolding. Furthermore, interactions between DEN E and
AL may have implications for the pathogenesis of dengue
hemorrhagic fever, which is characterized by activation of
endothelial cells and extracellular exposure of PS.
Materials and Methods
Cells
Vero, MA104, BHK21, BS-C-1, CHO-K1, RAW 264.7, U967,
and NIH3T3 cells (American Type Culture Collection (ATCC),
Manassas, VA), and HAb2 cells (a kind gift of Dr. Judith White,
University of Virginia), a line of NIH 3T3 cells stably expressing
A/Japan/305/57 influenza hemagglutinin (HA) in the immature
fusion-incompetent HA0 form [41] were grown in Advanced
DMEM medium (ADMEM) supplemented with 10% fetal bovine
serum, 25 mM HEPES, 2 mM glutamine, and antibiotics
(complete medium) at 37uC and 5% CO2. Aedes albopictus C6/36
(American Type Culture Collection, Rockville, MD) were cultured
in the complete medium at 28uC and 5% CO2. To facilitate
detection of cell fusion events by coplating differently labeled cells,
we developed Vero, CHO-K1, and BHK21 cells stably expressing
either EGFP or mRedFP according to the standard procedure
using pEGFP and pmRFP plasmids (kind gifts of Dr. Eugene
Zaitsev, NIH, NICHD).
Human red blood cells (RBC) were freshly isolated from whole
blood obtained from the National Institutes of Health (Bethesda,
MD) blood bank and labeled with a fluorescent lipid PKH26
(Sigma, St. Louis, MO), as described in [62–63].
Viruses
If not stated otherwise, we used dengue virus of serotype 2,
strain TH-36. In some experiments we used dengue virus of
serotype 2, strain New Guinea C and dengue virus of serotype 4,
strain H241. All viruses were purchased from ATCC. We
propagated DEN by inoculating monolayers of C6/36 cells or
Vero cells in complete medium in the presence of 0.005% Pluronic
F-127 (Invitrogen, Eugene, OR) at a multiplicity of infection
(MOI) of 0.1. DEN particles released from the cells were harvested
5 days postinfection and cleared from cell debris by means of low-
speed centrifugation. Working virus stocks with titers between 10
7
and 10
8 infectious units (IU)/ml were kept at 4uC for less than two
weeks. SIN strain AR-339 (ATCC) was used for infection of Vero
or C6/36 cells with a low multiplicity of infection to propagate the
working virus stocks with titer between 10
8–10
9 IU/ml. Virus was
collected 24-hours post-infection. DEN and SIN were titrated for
Vero cells using a fluorescent focus assay.
Viruses were concentrated by overnight centrifugation (SW28
rotor, 21 K rpm, 4uC) on a 55% cushion of Optiprep Density
Gradient medium (Sigma, St. Louis, MO) buffered with 20 mM
Tricine-HCl and 140 mM NaCl, pH 7.8 (buffer TrN) supple-
mented with 0.005% Pluronic F-127.
To label viral particles with a self-quenching concentration of a
fluorescent lipid, we mixed 10 ml of a 1 mM DiD solution from a
Vybrant cell-labeling kit (Molecular Probes, Eugene, OR) with
1 ml of 10% Pluronic F-127 and bath-sonicated the dispersion for
5 min. Freshly prepared DiD dispersion was injected into 1 ml of
virus stock (approximately 4610
8 IU) under intensive vortexing.
The mix was incubated for 30 min at room temperature and then
for 2 hr at 4uC. Labeled virus was purified from unincorporated
dye and from non-viral membranes and proteins by centrifugation
(SW55 rotor, 1.5 h, 53 K rpm, 4uC) on a 40%–25%–20%–15%
step gradient of Optipep density medium in TrN supplemented
with 0.005% Pluronic F-127. We collected the band between 20%
and 25% densities containing DiD-labeled virus. BSA (final
concentration 1%) was added to stabilize the preparation. Labeled
virus was used within 3 days. Before experiments, the viral
suspension was passed through a PES Millipore 0.22 mm filter to
remove viral aggregates. In fluorescence microscopy examination,
the number of DiD-labeled spots practically coincided with the
number of fluorescent spots observed when viral particles (DEN or
SIN) were visualized by immunofluorescence with DEN antibody
(MAB 8705) or SIN antibody (Sindbis Hyperimmune Ascetic
Fluid). DiD-labeled virus retained infectivity, but with an
approximately two-fold titer decrease.
Liposomes
All lipids used: Chol, PC (1,2-dioleoyl-sn-glycero-3-phosphocho-
line); PE (1,2-dioleoyl-sn-glycero-3-phosphoethanolamine); SPM
(N-oleoyl-D-erythro-sphingosylphosphorylcholine); PI (L-a-phos-
phatidylinositol, Soy); BMP (bis(monooleoylglycero)phosphate,
S,R Isomer); PS (1,2-dioleoyl-sn-glycero-3-phospho-L-serine); and
PG (1,2-dioleoyl-sn-glycero-3-phospho-(19-rac-glycerol)) were pur-
chased from Avanti Polar Lipids, Alabaster, AL. Liposomes were
formed from the following lipid mixtures: PM composition: PC,
phosphatidylethanolamine (PE), sphingomyelin (SPM), cholesterol
(Chol) in a molar ratio of 4/1/0.5/4.5; LEM composition, PC/
PE/phosphatidylinositol (PI)/BMP in a molar ratio of 5/2/1/2;
LEM-Chol composition, PC/PE/PI/BMP/Chol in a molar
ratio of 4/1/1/2/2) and from binary mixtures of PC with either
BMP, PG, or PS in a 7/3 molar ratio. To form large unilamellar
liposomes, lipid mixtures dissolved in benzene/methanol (95:5)
were frozen in liquid nitrogen and then freeze-dried under
vacuum overnight. Dry lipid powder was re-suspended in TrN
buffer by vigorous vortexing. We subjected the lipid suspension to
10 freeze-thaw cycles by alternating immersion into liquid
nitrogen and hot water. Finally, we extruded the lipid suspension
10 times through double-stacked track-etched 100 nm-pore
polycarbonate filters (GE Osmonics) using a LIPEX extruder.
Liposome sizes were checked using dynamic light scattering on N4
plus submicron particle size analyzer (Beckman Coulter, USA).
Liposomes were kept on ice and used within a day.
Virus binding
In all experiments that involved virus-to-cell binding we
incubated cells with viruses at 10uC. We found this temperature
to be optimal for DEN binding because at lower temperatures (for
instance, at 4uC) viral binding was very inefficient, and at higher
temperatures we observed internalization of viral particles by cells.
To compare cell binding for DEN with that for SIN, we surface-
biotinylated DEN and SIN particles by incubating viruses (10
6 IU)
with 10 mM EZ-Link Sulfo-NHS-SS-Biotin (Pierce Biotechnolo-
gy, Rockford, IL) in 0.5 mL phosphate buffer solution (PBS)
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30 min at room temperature. The reaction was quenched with
100 mM glycine in PBS. Biotinylated virus (10
5 IU of DEN or
SIN) was allowed to bind to lifted CHO-K1 cells (10
4 cells) at
10uC for 30 min. Cells were washed three times with cold serum-
free ADMEM medium supplemented with 1% BSA by pelleting at
4uC. After removing the unbound virus, we incubated the cells
with streptavidin Alexa Fluor 488 conjugate (Molecular Probes,
Eugene, OR) as recommended by the manufacturer and carried
out flow cytometry analysis using a FACSCanto fluorescence-
activated cell sorter (BD Biosciences).
In another experimental approach, we incubated the C6/36
and MA104 cells with DiD-labeled virus in 35 mm plates at 10uC
for 1 hr in the ADMEM medium. Unbound viral particles were
removed by washing, treated with 2.5 mM NBD-PC at 4uC for
5 min. The cells were washed with cold PBS. Then the cells were
lysed and DiD fluorescence dequenched by replacing PBS with
200 ml of PBC supplemented with 1% Triton X100. Samples were
cleared from debris by centrifugation. C6/36 cells are much
smaller than MA104 cells. To compare surface densities of bound
DEN particles at plasma membrane of C6/36 and MA104 cells,
we normalized the DiD fluorescence that provides a measure of
the amount of bound virus to the NBD fluorescence that provides
a measure of the total area of plasma membranes accessible for
NBD-PC insertion. This normalization is based on the assumption
that NBD-PC similarly partitions into the outer leaflets of plasma
membrane bilayers of different cells.
Viral infection assay
The effects of AL on virus infection were quantified in MA104,
Vero and BHK21 cells by fluorescent focus assay. Briefly, serial
dilutions of DEN in the ADMEM medium were incubated with
confluent monolayers of the cells at 10uC for 60 min. After
removing unbound viruses, the cells were treated with 2.5 mMo f
PS or PG in the ADMEM medium for 5 min at 4uC. The cells
were incubated at 37uC for 1 hour in the ADMEM medium, then
overlaid with the medium containing 2% FBS and supplemented
with 0.75% carboxymethyl-cellulose. The cells were grown for 3
days at 37uC and fluorescent focus units were detected by
immunostaining with the primary monoclonal antibody 4G2 and
fluorescent secondary antibodies against mouse IgG. Data were
normalized to control infection observed for the cells not treated
with any exogenous lipids.
Cell–cell fusion assays
Cells grown to high confluency were incubated with DEN or
SIN in complete medium for 30 min at 10uC. Unbound virus was
removed by three washes with cold PBS-T, and fusion was
triggered at room temperature by application of serum-free
ADMEM medium adjusted to different pH values with MES
and acetic acid. In unsuccessful attempts to achieve DEN-
mediated fusion of mammalian cells, we increased the MOI to
1,000 and extended the duration of the low-pH application to
15 min.
To detect virus-mediated fusion between mammalian cells by
redistribution of aqueous contents, we co–plated cells expressing
either EGFP or mRedFP at a 1:1 ratio. A day later, we incubated
the cells with virions (DEN, MOI of 300 or SIN, MOI of 40) as
described above, applied a 5-min low-pH pulse, and incubated
cells for 30 more minutes in the complete medium at 37uC. The
average number of co-labeled cells per microscopic field was
normalized to the average number of contacts between differently
labeled cells in the control experiment, in which cells were not
treated with low pH. For each condition, we carried out 3
independent experiments and analyzed at least 10 microscopic
fields in each experiment.
To score fusion between mosquito cells C6/36 with bound
DEN (MOI of 100) or SIN (MOI of 40) virions we treated the cells
with media of different pH for 15 min and then re-neutralized the
cells. After a 2-hour incubation at 37uC in complete medium we
quantified the efficiency of syncytium formation by measuring a
decrease in the number of mononucleated cells. More than 10
fields of view were analyzed for each experimental condition.
In the experiments on virus-mediated HAb2-RBC fusion, cells
with associated virions were incubated with PKH26-labeled RBCs
to achieve 0–2 bound RBC per cell [62]. After three washes with
PBS-T to remove unbound RBC, HAB2–virion–RBC complexes
were treated with PBS titrated with citrate to an acidic pH for
5 min and then re-neutralized with PBS-T. Fusion was quantified
as the ratio of dye-redistributed bound RBC to the total number of
bound RBC.
While the inability of DEN to fuse mammalian cells is illustrated
in the figures only for CHO-K1 cells and Vero cells and HAb2-
RBC fusion, we carried out similar experiments and observed no
DEN-mediated fusion for MA104, BHK21, BS-C-1, RAW 264.7,
U967, and NIH3T3 cells.
Virus–plasma membrane fusion
Fusion of DEN virions to the plasma membrane of MA104 cells,
Vero and BHK-21 cells was evaluated by a fusion-infection assay
(FIA) [34]. This assay is based on measuring infection caused by
low-pH-induced fusion between viral particles and plasma
membrane under conditions when endocytotic entry of virus is
blocked by inhibitors of endosomal acidification. We plated the
cells on Lab-tek II 8-well chambered coverglass (Nalge Nunc) a day
before experiment, then pre-treated them with 50 mM chloroquine
(Sigma, St. Louis, MO) for 30 min at 37uC. Viral particles were
allowed to bind to the cell surfaces at 10uC for 60 min (MOI =
300). After removal of unbound virus, the cells were treated (or not
treated) with 2.5 mM of PS or PG in the ADMEM medium for
5 min at 4uC. Fusion was triggered at room temperature by
replacing the medium with the ADMEM medium acidified to
pH 5.3. 5 min later the cells were neutralized, incubated at 37uC
for 4 hours in the ADMEM medium supplemented with
chloroquine. By that time, virions that did not infect the cells by
low pH-induced fusion to plasma membrane, have been internal-
ized and, because of the blocked endosomal acidification and, thus,
fusion, have already passed the endosomal compartments allowing
productive RNA release and infection. After this 4 hour incubation
in the presence of chloroquine, we overlaid the cells with the
ADMEM medium supplemented with 2% FBS and 0.75%
carboxymethyl cellulose to prevent virus spread. Fluorescent focus
units were detected 3 days later by immunostaining with the
antibody 4G2. Data were normalized to those obtained for the cells
that were not treated with AL. We found FIA assay for DEN and
mammalian cells to be very sensitive to the concentration of
chloroquine (and other inhibitors of endosomal acidification) and
the duration of the application of these inhibitors (longer
applications results in cytotoxity) and to MOI used.
Intracellular fusion assay
MA104 and BS-C-1 cells were grown on the coverglass bottom
of 35-mm tissue culture dishes (MatTek, MA) to high confluency.
DiD-labeled virus was added to cells (MOI of 100) and allowed to
bind for 30 min at 10uC. Unbound virus was removed by three
washes with cold PBS-T. The cells were warmed up to 37uCt o
allow virus internalization. After incubation of cells at 37uC for
different times, the cells were fixed with 4% paraformaldehyde
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virus within endosomes leads to dequenching of DiD and
appearance of bright fluorescent spots throughout the whole cell
but mostly in the perinuclear region. To quantify fusion efficiency,
we imaged cells with an iXon
EM+ 885 EMCCD Camera (Andor
Technology, CT) on an AxiObserver inverted fluorescence
microscope (Zeiss, Germany) using a Cy5-4040A filter set
(Semrock, NY). To capture signal from all fused viruses, we
collected image stacks throughout the cell with 250 nm spacing
between slices. We analyzed the acquired images using an ImageJ
macro developed in-house to measure the total fluorescence signal
from bright spots per imaging field (20 fields per experimental
condition were analyzed in each independent experiment; each
experiment was repeated at least three times).
Virus-liposome fusion
We assayed lipid mixing between DiD labeled viral particles
and liposomes as DiD dequenching in four-clear-sided methacry-
late cuvettes (Fisher Scientific, Pittsburgh, PA). The medium in the
cuvettes was continuously stirred with a magnetic stirring device
and thermostatted at 37uC. We mixed 10 ml( ,10
5 IU) of purified
labeled virus with liposomes (final concentration of lipid 30 mM) in
2 ml of TrN buffer. We initiated the fusion reaction by adding a
pre-titrated amount of MES/acetic acid buffer to reach the desired
pH. We recorded fluorescence for at least 15 min at excitation and
emission wavelengths of 620 and 665 nm, respectively, using an
Aminco Bowman Series 2 luminescence spectrometer (Rochester,
NY). At the end of each recording, we added Triton X-100 to a
final concentration of 0.1% to fully dequench DiD (‘‘100% lipid
mixing’’). We routinely verified that under our conditions the
efficiency of lipid mixing (rates and extents) was not limited by the
concentration of the liposomes used.
Virus inactivation by DEPC
DEN was inactivated by a 15-min incubation at room
temperature in PBS-T supplemented with 2 mM DEPC (Sigma,
St. Louis, MO) added from freshly prepared stock solution in cold
ethanol. DEPC was reported to inhibit vesicular stomatatis virus
by modifying histidine residues on viral protein fusogen [25].
Exogenous lipids
To add exogenous lipids (PS or PC or PG) to plasma membranes
of CHO-K1, MA104, BS-C-1 cells and HAb2–RBC pairs, we
incubated the cells with associated virions in a PBS supplemented
with 16:0-06:0 NBD PS (1-palmitoyl-2-{6-[(7-nitro-2-1,3-benzoxa-
diazol-4-yl)amino]hexanoyl}-sn-glycero-3-phosphoserine), 16:0-06:0
NBD PC (1-palmitoyl-2-{6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)ami-
no]hexanoyl}-sn-glycero-3-phosphocholine) or 16:0-06:0 NBD PG
(1-palmitoyl-2-{6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexano-
yl}-sn-glycero-3-[phospho-rac-(1-glycerol)]), all lipids purchased from
Avanti Polar Lipids, Alabaster, AL). A 2.5 mM stock solution (1 ml)
of PS, PC or PG in ethanol was injected into 1 ml of PBS-T under
intensive vortexing. The cells were cooled down to 4uC and placed
into this lipid-supplemented medium for 5 min, still at 4uC. We
inferred fromthe levelsofcell-associatedNBD fluorescenceobserved
with fluorescence microscopy that PS, PC and PG incorporated into
cell membranes to similar concentrations (see also [64]). For virus-
mediated cell–cellfusion,the lipid-supplementedbufferwas replaced
with warm (room temperature) serum-free ADMEM medium
adjusted to different pH values by titration with MES and acetic
acid. After the end of low pH application the cells were incubated at
37uC for 30 min and fusion was quantified by fluorescence
microscopy. We verified that at the time of low pH application a
significant part ofexogenous lipids remainextractable by delipidated
BSA. For the intracellular fusion assay, the cells with bound DiD-
labeled DEN or SIN virions were treated or not treated with
exogenous lipids as described above. The temperature was raised
and, after incubation at 37uC for different times, we fixed the cells
and analyzed them by fluorescence microscopy.
CPZ
To reveal DEN-mediated RH between HAb2 cells and PKH26-
labeled RBCs, a 5-min low pH pulse was followed by a 1-min
application of a 0.5 mM solution of CPZ (Sigma, St. Louis, MO)
in PBS-T. The percentage of HAb2–RBC pairs demonstrating
lipid mixing (PKH redistribution from RBC to HAb2 cell) was
assayed with fluorescence microscopy 20 min after the end of the
low–pH pulse.
Annexin V
Annexin V is widely used to evaluate the expression of PS on cell
surfaces [65]. We used this protein in two different experimental
approaches.To inhibitDENinteractions with PSinthe outerleaflet
of plasma membranes of C6/36 cells, we first incubated the cells in
annexin-binding buffer (BD Pharmingen, San Jose, CA) at room
temperature for 30 min and then allowed DEN or SIN virions to
bind to the cells. After removal of unbound virions, we incubated
the cells with 50 mg/ml recombinant annexin V (BD Pharmingen,
San Jose, CA) for 30 min at 10uC, washed the cells from unbound
annexin, and then triggered fusion by applying an acidic pH
medium. We verified that annexin V treatment had no effect on
virus–cell binding using DiD-labeled virions.
To compare PS expression at the surfaces of different cells, we
used R-phycoerythrin -tagged annexin V (BD Pharmingen, San
Jose, CA), as recommended by the manufacturer.
Lysosomotropic agents
In some experiments on intracellular fusion, to block endosomal
acidification we treated the cells with the lysosomotropic agents
chloroquine (Sigma, St. Louis, MO; 50 mM, 30 min, 37uC) or
bafilomycin-A1 (Sigma, St. Louis, MO; 2 mM, 30 min, 37uC)
prior to applying viral inoculum.
Dominant-negative Rab7
Cells were transfected using Lipofectamine 2000 (Invitrogen)
according to the manufacturer’s instructions with a EGFP-Rab7a
S22N plasmid [66], a kind gift from Julie Donaldson, NIH, on
Lab-tek II 4-well chambered coverglass (Nalge Nunc). 18 hours
later, DiD-labeled viral particles were allowed to bind to the cell
surfaces at 10uC for 60 min. After removal of unbound virus, cells
were treated (or not treated) with 2.5 mM of PS in the ADMEM
medium for 5 min at 4uC and then incubated in the ADMEM
medium at 37uC for 40 min. Cells were fixed and nuclei were
stained with DAPI (Invitrogen). Analysis by fluorescence micros-
copy allowed us to identify the transfected cells by their EGFP
fluorescence and to detect DEN fusion within endosomal pathway
as intracellular structures displaying DiD fluorescence.
Nocodazole
MA104 cells were preincubated with nocodazole (Sigma, St.
Louis, MO; 60 mM in complete medium, 30 min, 37uC) prior to
application of DEN and exogenous lipids. Nocodazole was present
throughout the entire experiment.
Supporting Information
Figure S1 DEN binding to C6/36 cells and MA104 cells. After
incubation of DiD-labeled virus with the cells at 10uC, the cells
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lowered to 4uC and NBD-PC was applied. After washing the cells,
we lysed them and measured DiD- and NBD- fluorescences. To
compare surface densities of bound DEN particles at plasma
membrane of the cells of the different sizes (C6/36 cells are much
smaller than MA104 cells), we normalized the DiD fluorescence
that provides a measure of the amount of bound virus to the NBD
fluorescence that provides a measure of the total area of plasma
membranes accessible for NBD-PC insertion. The data for C6/36
are taken as 100%. The data are presented as means +/- s.d, n=3.
Found at: doi:10.1371/journal.ppat.1001131.s001 (0.03 MB PDF)
Figure S2 The dependence of DEN-4 fusion on liposome
composition. Lipid mixing between DiD-labeled DEN-4 virions
and liposomes of LEM and PM compositions (pH 5.6, 37u)
assayed as DiD dequenching. In the negative controls, we
measured lipid mixing for LEM liposomes and DEN-4 virions
inactivated either by pre-incubation at pH 4.5 or by DEPC.
Found at: doi:10.1371/journal.ppat.1001131.s002 (0.07 MB PDF)
Figure S3 The dependence of SIN fusion to liposomes on
anionic lipids. Low-pH-dependent lipid mixing between DiD-
labeled SIN particles and liposomes of LEM-Chol (green bars) or
PM (red bars) compositions was measured at 37uCa sa
dequenching of DiD fluorescence at pH 5.3. No lipid mixing
was observed at neutral pH (striped bands). The data are
presented as extents of lipid mixing 10 min after acidification
and the initial rates of the lipid mixing (means +/2 s.d, n=3).
Found at: doi:10.1371/journal.ppat.1001131.s003 (0.04 MB PDF)
Figure S4 The dependence of SIN-mediated fusion of CHO-K1
cells on anionic lipids. CHO-K1 cells carrying SIN virions at their
surface were treated with PS or PG or not treated with exogenous
lipids (PS, PG, Low pH) immediately prior to a 5-min application
of pH 5.3. No fusion was observed if the cells were not exposed to
low pH (No low pH). After 30 min incubation in the complete
medium at 37uC, fusion was assayed with fluorescence microscopy
as the appearance of co-labeled cells. The average number of
fusion events (= the number of co-labeled cells) per microscopic
field was normalized to the average number of contacts between
differently labeled cells per field in the control experiment, in
which cells were not treated with low pH. For each condition, we
analyzed at least 10 microscopic fields.
Found at: doi:10.1371/journal.ppat.1001131.s004 (0.03 MB PDF)
Figure S5 Cell-surface labeling with Alexa Fluor 488-conjugated
annexin V for C6/36 cells than for Vero cells. The cells were pre-
incubated with annexin-binding buffer for 30 min at room
temperature and fluorescent annexin was applied in the same
buffer at concentration recommended by Invitrogen. Two panels
were photographed under the same settings to allow direct
comparison.
Found at: doi:10.1371/journal.ppat.1001131.s005 (0.88 MB PDF)
Figure S6 An increase in the rate of DEN fusion within
endocytic pathway for cells treated with exogenous PS. BS-C-1
cells were incubated with DiD-labeled DEN at 10uC for 30 min to
allow binding but not internalization of the virions. Unbound virus
was removed and the temperature was raised to 37uC to allow
virus to enter cells. Viral fusion events along the endocytic
pathway resulted in DiD dequenching and were detected as
appearance of fluorescent spots within the cells. A. - DiD
fluorescence (top panel) and phase contrast (bottom panel) images
of the cells treated and untreated with 2.5 mM of 16:0-06:0 NBD
PS (right and left images, respectively) taken 30 min after raising
the temperature. Scale bar, 25 mm. B. The cells were fixed at
different times after raising the temperature. Curves present time
course of an increase in the mean total fluorescence of the bright
spots per imaging field for untreated BS-C-1 cells (curve 2) and for
cells treated with 2.5 mM of 16:0-06:0 NBD PS (curve 1). Each
point is based on analysis of 20 fields for each experimental
condition in each of 3 independent experiments. The data are
normalized to the mean fluorescence observed for PS-treated cells
30 min after raising the temperature and presented as mean +/2
s.d.
Found at: doi:10.1371/journal.ppat.1001131.s006 (0.38 MB PDF)
Figure S7 Inhibition of intracellular fusion of DiD-labeled DEN
in MA104 cells transfected with dominant negative EGFP-tagged
Rab7a S22N is alleviated by treating the cells with PS. A. In
contrast to surrounding cells, identified by the presence of DAPI-
stained (blue) nuclei, DN Rab7a-expressing cell, identified by its
green (EGFP) fluorescence, contains almost no DiD labeled
(orange) structures. B. Image on the right. Treating the cells with
PS alleviated the DN Rab7a inhibition of DEN fusion, as
evidenced by multiple DiD labeled structures observed within a
green (DN Rab7a-expressing) PS-treated cell. Image on the left,
taken with the same settings as image on the right, shows, similarly
to A, the lack of DiD structures in DN Rab7a expressing cell.
Found at: doi:10.1371/journal.ppat.1001131.s007 (0.29 MB PDF)
Figure S8 In SIN-mediated cell fusion, transition from the
restricted hemifusion to lipid mixing at optimal pH requires
neither PS nor CPZ application. pH dependence of the SIN-
mediated fusion for the cells treated or not treated with PS and/or
with CPZ (0.5 mM, applied for 1 min). HAb2-SIN-PKH26-
labeled RBC complexes were treated for 5 min with medium of a
given pH to trigger conformational changes in protein fusogens
and, thus, fusion. Fusion was assayed as a percentage of HAb2-
SIN-RBC complexes demonstrating lipid mixing 20 min after the
end of the low pH application. (1) - HAb2-SIN-RBC complexes
treated with neither PS nor CPZ. (2) - HAb2-SIN-RBC com-
plexes treated with PS immediately prior to low pH applica-
tion. (3) - HAb2-SIN-RBC complexes treated with CPZ pulse
immediately after the end of low pH application. (4) - HAb2-
SIN-RBC complexes treated with PS immediately prior to
low pH application and with CPZ pulse immediately after the
end of low pH application. The data presented as mean +/2 s.d.,
n=3.
Found at: doi:10.1371/journal.ppat.1001131.s008 (0.04 MB PDF)
Acknowledgments
We are indebted to Julie G. Donaldson, Ana P. Goncalvez, Stephen S.
Whitehead, and Eugene N. Zaitsev for generous gifts of antibodies and
constructs. We thank Michael M. Kozlov, Gregory Melikyan, Theodore
Pierson, Stephen S. Whitehead, Eugene N. Zaitsev and Joshua Zimmer-
berg for very helpful discussions and Margaret Kielian for advice on fusion-
infection assay.
Author Contributions
Conceived and designed the experiments: EZ STY KM LVC. Performed
the experiments: EZ STY SP. Analyzed the data: EZ STY KM SP LVC.
Wrote the paper: EZ KM LVC.
References
1. Kyle JL, Harris E (2008) Global spread and persistence of dengue. Annu Rev
Microbiol 62: 71–92.
2. Stiasny K, Heinz FX (2006) Flavivirus membrane fusion. J Gen Virol 87:
2755–2766.
Lipid Cofactors of Dengue Virus Fusion Machinery
PLoS Pathogens | www.plospathogens.org 13 October 2010 | Volume 6 | Issue 10 | e10011313. van der Schaar HM, Rust MJ, Chen C, van der Ende-Metselaar H, Wilschut J,
et al. (2008) Dissecting the cell entry pathway of dengue virus by single-particle
tracking in living cells. PLoS Pathog 4: e1000244.
4. Mosso C, Galvan-Mendoza IJ, Ludert JE, del Angel RM (2008) Endocytic
pathway followed by dengue virus to infect the mosquito cell line C6/36 HT.
Virology 378: 193–199.
5. Panyasrivanit M, Khakpoor A, Wikan N, Smith DR (2009) Linking dengue virus
entry and translation/replication through amphisomes. Autophagy 5: 434–435.
6. Harrison SC (2008) Viral membrane fusion. Nat Struct Mol Biol 15: 690–698.
7. Mukhopadhyay S, Kuhn RJ, Rossmann MG (2005) A structural perspective of
the flavivirus life cycle. Nat Rev Microbiol 3: 13–22.
8. Kielian M, Rey FA (2006) Virus membrane-fusion proteins: more than one way
to make a hairpin. Nat Rev Microbiol 4: 67–76.
9. Nayak V, Dessau M, Kucera K, Anthony K, Ledizet M, et al. (2009) Crystal
structure of dengue virus type 1 envelope protein in the postfusion conformation
and its implications for membrane fusion. J Virol 83: 4338–4344.
10. Weissenhorn W, Hinz A, Gaudin Y (2007) Virus membrane fusion. FEBS Lett
581: 2150–2155.
11. Schmidt AG, Yang PL, Harrison SC (2010) Peptide inhibitors of dengue-virus
entry target a late-stage fusion intermediate. PLoS Pathog 6: e1000851.
12. Liao M, Sanchez-San Martin C, Zheng A, Kielian M (2010) In Vitro
Reconstitution Reveals Key Intermediate States of Trimer Formation by the
Dengue Virus Membrane Fusion Protein. J Virol.
13. Randolph VB, Stollar V (1990) Low pH-induced cell fusion in flavivirus-infected
Aedes albopictus cell cultures. J Gen Virol 71(Pt 8): 1845–1850.
14. Summers PL, Cohen WH, Ruiz MM, Hase T, Eckels KH (1989) Flaviviruses
can mediate fusion from without in Aedes albopictus mosquito cell cultures.
Virus Res 12: 383–392.
15. Guirakhoo F, Hunt AR, Lewis JG, Roehrig JT (1993) Selection and partial
characterization of dengue 2 virus mutants that induce fusion at elevated pH.
Virology 194: 219–223.
16. Kielian MC, Helenius A (1984) Role of cholesterol in fusion of Semliki Forest
virus with membranes. J Virol 52: 281–283.
17. Smit JM, Bittman R, Wilschut J (1999) Low-pH-dependent fusion of Sindbis
virus with receptor-free cholesterol- and sphingolipid-containing liposomes.
J Virol 73: 8476–8484.
18. Kielian M, Chatterjee PK, Gibbons DL, Lu YE (2000) Specific roles for lipids in
virus fusion and exit. Examples from the alphaviruses. Subcell Biochem 34:
409–455.
19. Umashankar M, Sanchez-San Martin C, Liao M, Reilly B, Guo A, et al. (2008)
Differential cholesterol binding by class II fusion proteins determines membrane
fusion properties. J Virol 82: 9245–9253.
20. Coil DA, Miller AD (2004) Phosphatidylserine is not the cell surface receptor for
vesicular stomatitis virus. J Virol 78: 10920–10926.
21. Kobayashi T, Beuchat MH, Chevallier J, Makino A, Mayran N, et al. (2002)
Separation and characterization of late endosomal membrane domains. J Biol
Chem 277: 32157–32164.
22. Stegmann T, Hoekstra D, Scherphof G, Wilschut J (1986) Fusion activity of
influenza virus. A comparison between biological and artificial target membrane
vesicles. J Biol Chem 261: 10966–10969.
23. Chen A, Leikina E, Melikov K, Podbilewicz B, Kozlov M, et al. (2008) Fusion
pore expansion during syncytium formation is restricted by an actin network.
Journal of Cell Science in press.
24. Edwards J, Mann E, Brown DT (1983) Conformational changes in Sindbis virus
envelope proteins accompanying exposure to low pH. J Virol 45: 1090–1097.
25. Da Poian AT, Carneiro FA, Stauffer F (2009) Viral inactivation based on
inhibition of membrane fusion: understanding the role of histidine protonation
to develop new viral vaccines. Protein Pept Lett 16: 779–785.
26. Gentry MK, Henchal EA, McCown JM, Brandt WE, Dalrymple JM (1982)
Identification of distinct antigenic determinants on dengue-2 virus using
monoclonal antibodies. Am J Trop Med Hyg 31: 548–555.
27. White J, Matlin K, Helenius A (1981) Cell fusion by Semliki Forest, influenza,
and vesicular stomatitis viruses. J Cell Biol 89: 674–679.
28. Kielian MC, Keranen S, Kaariainen L, Helenius A (1984) Membrane fusion
mutants of Semliki Forest virus. J Cell Biol 98: 139–145.
29. Lee H, Brown DT (1994) Mutations in an exposed domain of Sindbis virus
capsid protein result in the production of noninfectious virions and morpho-
logical variants. Virology 202: 390–400.
30. Smit JM, Li G, Schoen P, Corver J, Bittman R, et al. (2002) Fusion of
alphaviruses with liposomes is a non-leaky process. FEBS Lett 521: 62–66.
31. Thongthai W, Weninger K (2009) Photoinactivation of sindbis virus infectivity
without inhibition of membrane fusion. Photochem Photobiol 85: 801–806.
32. Wessels L, Elting MW, Scimeca D, Weninger K (2007) Rapid membrane fusion
of individual virus particles with supported lipid bilayers. Biophys J 93: 526–538.
33. Fadeel B, Xue D (2009) The ins and outs of phospholipid asymmetry in the
plasma membrane: roles in health and disease. Crit Rev Biochem Mol Biol 44:
264–277.
34. Liao M, Kielian M (2005) Domain III from class II fusion proteins functions as a
dominant-negative inhibitor of virus membrane fusion. J Cell Biol 171: 111–120.
35. Yeung T, Heit B, Dubuisson JF, Fairn GD, Chiu B, et al. (2009) Contribution of
phosphatidylserine to membrane surface charge and protein targeting during
phagosome maturation. J Cell Biol 185: 917–928.
36. Bayer N, Schober D, Prchla E, Murphy RF, Blaas D, et al. (1998) Effect of
bafilomycin A1 and nocodazole on endocytic transport in HeLa cells:
implications for viral uncoating and infection. J Virol 72: 9645–9655.
37. Carr CM, Kim PS (1993) A spring-loaded mechanism for the conformational
change of influenza hemagglutinin. Cell 73: 823–832.
38. Schmid S, Fuchs R, Kielian M, Helenius A, Mellman I (1989) Acidification of
endosome subpopulations in wild-type Chinese hamster ovary cells and
temperature-sensitive acidification-defective mutants. J Cell Biol 108:
1291–1300.
39. Chernomordik LV, Kozlov MM (2003) Protein-lipid interplay in fusion and
fission of biological membranes. Annu Rev Biochem 72: 175–207.
40. Melikyan GB, Brener SA, Ok DC, Cohen FS (1997) Inner but not outer
membrane leaflets control the transition from glycosylphosphatidylinositol-
anchored influenza hemagglutinin-induced hemifusion to full fusion. J Cell Biol
136: 995–1005.
41. Doxsey SJ, Sambrook J, Helenius A, White J (1985) An efficient method for
introducing macromolecules into living cells. J Cell Biol 101: 19–27.
42. Spruce AE, Iwata A, White JM, Almers W (1989) Patch clamp studies of single
cell-fusion events mediated by a viral fusion protein. Nature 342: 555–558.
43. Zaitseva E, Mittal A, Griffin DE, Chernomordik LV (2005) Class II fusion
protein of alphaviruses drives membrane fusion through the same pathway as
class I proteins. J Cell Biol 169: 167–177.
44. Corver J, Ortiz A, Allison SL, Schalich J, Heinz FX, et al. (2000) Membrane
fusion activity of tick-borne encephalitis virus and recombinant subviral particles
in a liposomal model system. Virology 269: 37–46.
45. Fritz R, Stiasny K, Heinz FX (2008) Identification of specific histidines as pH
sensors in flavivirus membrane fusion. J Cell Biol 183: 353–361.
46. Nieva JL, Bron R, Corver J, Wilschut J (1994) Membrane fusion of Semliki
Forest virus requires sphingolipids in the target membrane. EMBO J 13:
2797–2804.
47. Klimjack MR, Jeffrey S, Kielian M (1994) Membrane and protein interactions of
a soluble form of the Semliki Forest virus fusion protein. J Virol 68: 6940–6946.
48. Samsonov AV, Chatterjee PK, Razinkov VI, Eng CH, Kielian M, et al. (2002)
Effects of membrane potential and sphingolipid structures on fusion of Semliki
Forest virus. J Virol 76: 12691–12702.
49. McLaughlin S (1989) The Electrostatic Properties of Membranes. . pp 113–136.
50. Stauffer F, Melo MN, Carneiro FA, Sousa FJ, Juliano MA, et al. (2008)
Interaction between dengue virus fusion peptide and lipid bilayers depends on
peptide clustering. Mol Membr Biol 25: 128–138.
51. Poh MK, Yip A, Zhang S, Priestle JP, Ma NL, et al. (2009) A small molecule
fusion inhibitor of dengue virus. Antiviral Res 84: 260–266.
52. White J, Helenius A (1980) pH-dependent fusion between the Semliki Forest
virus membrane and liposomes. Proc Natl Acad Sci U S A 77: 3273–3277.
53. Stiasny K, Brandler S, Kossl C, Heinz FX (2007) Probing the flavivirus
membrane fusion mechanism by using monoclonal antibodies. J Virol 81:
11526–11531.
54. Gollins SW, Porterfield JS (1986) pH-dependent fusion between the flavivirus
West Nile and liposomal model membranes. J Gen Virol 67: 157–166.
55. Waarts BL, Bittman R, Wilschut J (2002) Sphingolipid- and cholesterol-
dependence of alphavirus membrane fusion: Lack of correlation with lipid raft
formation in target liposomes. J Biol Chem 23: 23.
56. van der Schaar HM (2009) Cell entry mechanisms of dengue virus: University of
Groningen. 160 p.
57. van der Schaar HM, Rust MJ, Waarts BL, van der Ende-Metselaar H, Kuhn RJ,
et al. (2007) Characterization of the early events in dengue virus cell entry by
biochemical assays and single-virus tracking. J Virol 81: 12019–12028.
58. Le Blanc I, Luyet PP, Pons V, Ferguson C, Emans N, et al. (2005) Endosome-to-
cytosol transport of viral nucleocapsids. Nat Cell Biol 7: 653–664.
59. Johannsdottir HK, Mancini R, Kartenbeck J, Amato L, Helenius A (2009) Host
cell factors and functions involved in vesicular stomatitis virus entry. J Virol 83:
440–453.
60. Acosta EG, Castilla V, Damonte EB (2009) Alternative infectious entry pathways
for dengue virus serotypes into mammalian cells. Cell Microbiol 11: 1533–1549.
61. Krishnan MN, Sukumaran B, Pal U, Agaisse H, Murray JL, et al. (2007) Rab 5
is required for the cellular entry of dengue and West Nile viruses. J Virol 81:
4881–4885.
62. Chernomordik LV, Frolov VA, Leikina E, Bronk P, Zimmerberg J (1998) The
pathway of membrane fusion catalyzed by influenza hemagglutinin: restriction
of lipids, hemifusion, and lipidic fusion pore formation. J Cell Biol 140:
1369–1382.
63. Melikyan GB, Jin H, Lamb RA, Cohen FS (1997) The role of the cytoplasmic
tail region of influenza virus hemagglutinin in formation and growth of fusion
pores. Virology 235: 118–128.
64. Endo TA, Kobayashi T, Ohki K (1996) A Chinese hamster ovary cell mutant
resistant to phosphatidylserine is defective in transbilayer movement of cell
surface phosphatidylserine. Exp Cell Res 228: 341–346.
65. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C (1995) A novel
assay for apoptosis.Flow cytometric detection of phosphatidylserine expression
on early apoptotic cells using fluorescein labelled Annexin V. J Immunol
Methods 184: 39–51.
66. Naslavsky N, Weigert R, Donaldson JG (2003) Convergence of non-clathrin-
and clathrin-derived endosomes involves Arf6 inactivation and changes in
phosphoinositides. Mol Biol Cell 14: 417–431.
Lipid Cofactors of Dengue Virus Fusion Machinery
PLoS Pathogens | www.plospathogens.org 14 October 2010 | Volume 6 | Issue 10 | e1001131